OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-MARK4 antibodies

Anti-MARK4 Antibody

div

Specifications Citations (0) Related Products Product Documents
SKU Description Amount Price Availability*  
TA302535 Goat Polyclonal Antibody against MARK4 100ug $325 3-7 Days
LC403112 MARK4 HEK293T cell transient overexpression lysate (as WB positive control) 20ug $50 In Stock
Add to Shopping Cart

spacer
WB(1)

OriGene Data

ImmunogenPeptide with sequence IKRKPPPGCSDSPGV, from the C Terminus of the protein sequence according to NP_113605.2.
Clone Name IsotypeGoat IgG
Species ReactivityTest: Human. Expected from seq similarity: Human Concentration0.5 mg/ml
Guaranteed Application *WB Suggested DilutionsELISA: 1:128,000. WB: 0.3-1µg/ml.
Predicted MW Explanation 78952Da
BufferSupplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Purification Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.

Reference Data

Target NameHomo sapiens MAP/microtubule affinity-regulating kinase 4 (MARK4), transcript variant 2
Alternative NameMARK4L; MARK4S; MARKL1; MARKL1L; PAR-1D
Database LinkNP_113605
Entrez Gene 57787 Human
Function
Related PathwayProtein KinaseDruggable Genome

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

TA302535 (0.5µg/ml) staining of human prostate lysate (35µg protein in RIPA buffer). Primary incubated for 1 hour. Detected by western blot using chemiluminescence.
spacer

 

spacer
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title